Jan Korniluk

Overexpression of epidermal growth factor receptor as a prognostic factor in colorectal cancer on the basis of the Allred scoring system

Marta Rokita, Rafał Stec, Lubomir Bodnar et al. · OncoTargets and Therapy · 2013 · 34 citations · Full text

Medicine, Oncology, Pathology +17

Feasibility, Efficacy and Safety of Tyrosine Kinase Inhibitor Treatment in Hemodialyzed Patients with Renal Cell Cancer: 10 Years of Experience

Anna M. Czarnecka, Maciej Kawecki, Fei Lian et al. · Future Oncology · 2015 · 30 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Impact of relative dose intensity of oxaliplatin in adjuvant therapy among stage III colon cancer patients on early recurrence: a retrospective cohort study

Jolanta Żok, Michał Bieńkowski, Barbara Radecka et al. · BMC Cancer · 2021 · 20 citations · Full text

Medicine, Oncology, Surgery +17

Long-term response to sunitinib: everolimus treatment in metastatic clear cell renal cell carcinoma

Anna M. Czarnecka, Paweł Sobczuk, Jan Korniluk et al. · Future Oncology · 2016 · 19 citations

Medicine, Oncology, Pharmacology +14

<i><i>K-Ras</i></i> gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan- or oxaliplatin-based chemotherapy

Rafał Stec, Lubomir Bodnar, Radosław Charkiewicz et al. · Cancer Biology & Therapy · 2012 · 13 citations · Full text

Medicine, Molecular Genetics, Oncology +17